News
Contact
Home
TSX:DND
3.71
+
0.05
+
1.37%
Volume:
9,900
May 17, 2013
About Us
Overview
Leadership Team
Board of Directors
Products
Overview
Lipofen®
ConZip® / Durela®
CIP-Isotretinoin
Partnerships & Alliances
Investor Relations
Overview
Analyst Coverage
Financial Reports & Filings
Events & Presentations
Stock Quote / Chart
News
Investor Contact
Email Alerts
RSS Feeds
Investor Relations
Overview
Analyst Coverage
Financial Reports & Filings
Events & Presentations
Stock Quote / Chart
News
Investor Contact
Email Alerts
RSS Feeds
Overview
Analyst Coverage
Financial Reports & Filings
Events & Presentations
Stock Quote / Chart
News
Investor Contact
Email Alerts
RSS Feeds
Home
>
Investor Relations
>
Financial Reports & Filings
Financial Reports & Filings
Fiscal 2013
Date
Download
May 2, 2013
Q1 Report
344 KB
Fiscal 2012
Date
Download
December 31, 2012
Annual Report
706 KB
September 30, 2012
Q3 Report
1.22 MB
June 30, 2012
Q2 Report
1.25 MB
March 31, 2012
Q1 Report
1.23 MB
Fiscal 2011
Thumb
Date
Download
December 31, 2011
Annual Report
2.37 MB
September 30, 2011
Q3 Report
487 KB
June 30, 2011
Q2 Report
976 KB
March 31, 2011
Q1 Report
429 KB
Fiscal 2010
Thumb
Date
Download
December 31, 2010
Annual Report
610 KB
September 30, 2010
Q3 Report
474 KB
June 30, 2010
Q2 Report
616 KB
March 31, 2010
Q1 Report
610 KB
Thumb
Download
View our Annual Report
706 KB
Disclaimer
Contact
Home
©2012 Cipher Pharmaceuticals Inc.
Powered By Q4 Web Systems
3.8.1.5343